IGFBP2 and leukemia: However, within the GFP+ leukemia compartments, there were no significant differences in the AML-SC population or in the more differentiated Mac-1+, B220+, or CD3+ cells in mice that received IGFBP2-null cells and in those transplanted with wild-type cells based on flow cytometry analyses (Figure 3D).